Immunotherapy has been one of the most transformative treatments for cancer patients in recent decades, shifting the emphasis ...
How has the combination of antibody-drug conjugate and checkpoint inhibitors revolutionized treatment for patients with metastatic urothelial cancer? The clinical results from several trials suggest ...
ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegenerative diseases, today presented new data from the first clinical study in Alzheimer's disease ...
Immune Checkpoint Blockade in Deficient Mismatch Repair/Microsatellite Instability-High Gastric Cancer: Solid Evidence or Premature Extrapolation? The following represents disclosure information ...
For decades, cancer immunotherapy has focused primarily on CD8+ cytotoxic T lymphocytes as the main executors of tumor cell ...
This session, from the 2025 IO360 Summit, focuses on different strategies to augment immune response in urothelial carcinoma, presented by Dr Jonathan Rosenberg, Memorial Sloan Kettering Cancer Center ...
A research team investigating the use of the bacterium Listeria monocytogenes against colorectal cancer has discovered a way to build a modified version of Listeria as an oral vaccine to prime the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results